Radiotherapy & Oncology
Volume 96, Issue 1 , Pages 34-37 , July 2010

Outcomes from Gleason 7, intermediate risk, localized prostate cancer treated with Iodine-125 monotherapy over 10years

  • Nicholas P. Munro

      Affiliations

    • Department of Urology, St James’s Institute of Oncology, St James’s University Hospital, Leeds, UK
    • Corresponding Author InformationCorresponding author. Address: 48 Franklin road, Harrogate, North Yorkshire, HG1 5EE, UK.
    • ,
  • Bashar Al-Qaisieh

      Affiliations

    • Department of Medical Physics, St James’s Institute of Oncology, St James’s University Hospital, Leeds, UK
    • ,
  • Peter Bownes

      Affiliations

    • Department of Medical Physics, St James’s Institute of Oncology, St James’s University Hospital, Leeds, UK
    • ,
  • Jonathan Smith

      Affiliations

    • Department of Clinical Radiology, St James’s Institute of Oncology, St James’s University Hospital, Leeds, UK
    • ,
  • Brendan Carey

      Affiliations

    • Department of Clinical Radiology, St James’s Institute of Oncology, St James’s University Hospital, Leeds, UK
    • ,
  • David Bottomley

      Affiliations

    • Department of Clinical Oncology, St James’s Institute of Oncology, St James’s University Hospital, Leeds, UK
    • ,
  • Dan Ash

      Affiliations

    • Department of Clinical Oncology, St James’s Institute of Oncology, St James’s University Hospital, Leeds, UK
    • ,
  • Ann M. Henry

      Affiliations

    • Department of Clinical Oncology, St James’s Institute of Oncology, St James’s University Hospital, Leeds, UK

Received 6 February 2009 ,Revised 27 February 2010 ,Accepted 7 March 2010.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

PII: S0167-8140(10)00155-6

doi: 10.1016/j.radonc.2010.03.004

Radiotherapy & Oncology
Volume 96, Issue 1 , Pages 34-37 , July 2010

Article Tools

* Image Usage & Resolution